Skip to main content
OpenTrials

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

116 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Completed

Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma

NCT00227669

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Centre Hospitalier Universitaire d'Amiens Amiens, France
  • Centre Paul Papin Angers, France
  • C.H.G. Beauvais Beauvais, France
  • Institut Bergonie Bordeaux, France
View all 32 locations
View Trial Details
Completed

Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis

NCT00091351

Conditions
Fibrosarcoma, Hemangiosarcoma, Histiocytoma, +23 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States
  • George Washington University Medical Center Washington D.C., District of Columbia, United States
View all 59 locations
View Trial Details
Completed

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

NCT00720174

Conditions
Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, Adult Epithelioid Sarcoma, +64 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Decatur, Illinois, United States
  • NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States
  • Ingalls Memorial Hospital Harvey, Illinois, United States
View all 13 locations
View Trial Details
Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions